Clinical Trial

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

Name: Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients — clinical trial record (NCT06922045)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study will assess the efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor

Protocol Amendment History 1 change

critical Enrollment closed, study ongoing 2026-08-13

Trial Details

NCT Number	NCT06922045
Lead Sponsor	Jiangsu BioJeTay Biotechnology Co., Ltd.
Conditions	Hemophilia
Enrollment	40 participants
Start Date	2025-03-26
Primary Completion	2026-09 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-12